INS and Hypoglycemia: The lack of newly diagnosed/treated patients (<12 months insulin use) in HAT could affect the observed rates of hypoglycaemia; however, this group is only a small proportion of the total population with T2DM and is unlikely to have a significant effect on the mean values.